Prosecution Insights
Last updated: November 20, 2026
Application No. 18/881,420

LAVAGE SYSTEMS AND DEVICES HAVING A FLOW-ADJUSTING MEMBER

Non-Final OA §102§103§112
Filed
Jan 06, 2025
Priority
Jul 05, 2022 — provisional 63/358,401 +1 more
Examiner
SHAH, NILAY J
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Cardinal Health Inc.
OA Round
1 (Non-Final)
76%
Grant Probability
Favorable
1-2
OA Rounds
1y 3m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 76% — above average
76%
Career Allowance Rate
470 granted / 617 resolved
+6.2% vs TC avg
Strong +47% interview lift
Without
With
+47.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
59 currently pending
Career history
696
Total Applications
across all art units

Statute-Specific Performance

§101
1.4%
-38.6% vs TC avg
§103
49.7%
+9.7% vs TC avg
§102
15.6%
-24.4% vs TC avg
§112
30.8%
-9.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 617 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Objections Claims 1, 4, 21 are objected to because of the following informalities: Regarding claim 1, line 2, the recitation “lavage fluid” (both instances) appears to be amended to recite “the lavage fluid” in order to refer to “a lavage fluid” recited in line 1. Regarding claim 4, applicant is advised to use either “body” or “sealed body” to refer to the same limitation consistently instead of interchangeably referring the limitation with different terms. Regarding claim 21, the recitation “lavage fluid” appears to be amended to recite “the lavage fluid” in order to refer to “a lavage fluid” recited in claim 1, line 2. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 21 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding claim 21, the recitation “wherein the sealed body and lavage fluid … via gamma radiation” renders the claim indefinite because the claim is unclear if the claim is positively reciting the step of terminally-sterilizing via gamma radiation or is claiming that the sealed body and lavage fluid are both terminally-sterile via gamma radiation. For examination purposes, examiner construes that the sealed body and lavage fluid are both sterile by using the process of terminally-sterilized via gamma radiation. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-5 and 7-14 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Schultz et al. (US 8,747,372 B1). Regarding claim 1, Schultz teaches a system (figure 14) for applying a lavage fluid 56 to a surface, the system comprising: a sealed body 59 containing a lavage fluid 56, wherein the sealed body 59 and lavage fluid 56 contained therein are terminally-sterilized (examiner construes that fluid is sterilized because Schultz discloses maintaining sterility at several places, column 8, lines 40-46, column 9, line 36, column 16, lines 50-54 and whether the fluid is sterilized prior to filling or terminally-sterilized, the final output is being sterile which is the case in Schultz); and a flow-adjusting member 64B, wherein the flow-adjusting member 64B is configured to create a disruption (column 15, lines 41-43) in the sealed body to facilitate discharge of the lavage fluid in a flow pattern. Regarding claim 2, Schultz teaches wherein the flow-adjusting member 64B comprises a tool 65B with a tapered end (end of element 65B is tapered as shown in figure 14). Regarding claim 3, Schultz teaches wherein the flow-adjusting member 64B comprises a spike cap 64B configure to be attached a first end (end of element 59 where element 64B is connected) of the sealed body 59, wherein the spike cap comprises a spike geometry (geometry of element 65B). Regarding claim 4, Schultz teaches wherein the body 59 comprises buttress threads (column 9, lines 43-50) on the first end of the sealed body 59. Regarding claim 5, Schultz teaches wherein the spike cap 64B further comprises buttress threads 69 (column 9, lines 43-50) which attach to the buttress threads on the first end of the sealed body. Regarding claim 7, Schultz teaches wherein the spike geometry comprises an aligned tip (tip of element 65B). Regarding claim 8, Schultz teaches wherein the flow-adjusting member 64B is separate from the sealed body 59 (element 64B is a separate component attached to the sealed body and examiner construes “separate” as being two components that are being manufactured separately instead of an integrated one body. Furthermore, one can disconnect element 64B and element 59 would still be able to discharge the lavage fluid because element 64B has already damaged the membrane to let the fluid flow) during the discharge of the lavage fluid. Regarding claim 9, Schultz teaches wherein the flow-adjusting member 64B is in fluid communication (column 15, lines 41-48, figure 14) with the sealed body 59 during discharge of the lavage fluid. Regarding claim 10, Schultz teaches wherein the flow-adjusting member 64B creates a cut (cut in membrane 59A) in the sealed body 59, wherein a shape and size of the cut (the shape and size of cut in element 59A would determine the flow pattern) determines the flow pattern of the lavage fluid. Regarding claim 11, Schultz teaches wherein the sealed body 59 is compressible (column 15, lines 62-65, “squeezed”), and the sealed body 59 is configured such that at least a portion of the lavage fluid is discharged through the disruption, upon compression of the sealed body (column 15, lines 62-65). Regarding claim 12, Schultz teaches wherein the sealed body 59 is configured such that at least a portion of the lavage fluid is discharged through the disruption, with or without compression of the sealed body (column 15, lines 62-65). Regarding claim 13, Schultz teaches wherein the sealed body 59 is collapsible (column 15, lines 62-65, “squeezed”). Regarding claim 14, Schultz teaches wherein the flow-adjusting member 64B is integral (upon threading element 64B becomes integral to element 59) to the sealed body 59. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim 6 is rejected under 35 U.S.C. 103 as being unpatentable over Schultz et al. (US 8,747,372 B1) in view of Post et al. (US 5,492,531). Regarding claim 6, Schultz discloses the claimed invention substantially as claimed, as set forth above in claims 1 and 3. Schultz is silent regarding wherein the spike geometry comprises a bevel tip. However, Post teaches a design of a lavage system 10 (figure 1) wherein the spike geometry (geometry of element 78 in figure 2) comprises a bevel tip 80 (column 4, lines 33-38) for the purpose of using a well-known alternative structure to pierce the membrane (column 4, lines 33-38). Therefore, it would have been prima facie obvious to one of ordinary skill in the art, before the effective filing of the claimed invention to modify the wherein the spike geometry comprises a bevel tip as taught by Post for the purpose of using a well-known alternative structure to pierce the membrane (column 4, lines 33-38). Claim(s) 15 is rejected under 35 U.S.C. 103 as being unpatentable over Schultz et al. (US 8,747,372 B1) in view of Brown et al. (US 2020/0188612 A1). Regarding claim 15, Schultz discloses the claimed invention substantially as claimed, as set forth above in claim 1. Schultz is silent regarding wherein the lavage fluid comprises a chemical agent and water, the chemical agent comprising iodine. However, Brown teaches a system and method for reducing contaminants into the patient (figure 1) wherein the lavage fluid comprises a chemical agent and water, the chemical agent comprising iodine (paragraph 0098, lines 4-18) for the purpose of reducing biofilm and contaminants that can be cytotoxic when performing a medical procedure (paragraph 0098, lines 4-18). Therefore, it would have been prima facie obvious to one of ordinary skill in the art before the effective filing of the claimed invention to modify the lavage fluid of Schultz to incorporate wherein the lavage fluid comprises a chemical agent and water, the chemical agent comprising iodine as taught by Brown for the purpose of reducing biofilm and contaminants that can be cytotoxic when performing a medical procedure (paragraph 0098, lines 4-18). Claim(s) 16 is rejected under 35 U.S.C. 103 as being unpatentable over Schultz et al. (US 8,747,372 B1) in view of Gobel (US 2019/0192836 A1). Regarding claim 16, Schultz discloses the claimed invention substantially as claimed, as set forth above in claim 1. Schultz is silent regarding wherein the flow pattern comprises substantially all of the lavage fluid being discharged from the sealed body within 20 seconds. However, Gobel teaches a system for lavage wherein the flow pattern comprises substantially all of the lavage fluid being discharged from the sealed body within 20 seconds (paragraphs 0018-019) for the purpose of washing the body organ when performing a medical procedure (paragraph 0018). Therefore, it would have been prima facie obvious to one of ordinary skill in the art, to modify the flow pattern of Schultz to incorporate wherein the flow pattern comprises substantially all of the lavage fluid being discharged from the sealed body within 20 seconds as taught by Gobel for the purpose of washing the body organ when performing a medical procedure (paragraph 0018). Claim 17 is rejected under 35 U.S.C. 103 as being unpatentable over Schultz et al. (US 8,747,372 B1) in view of Morse (US 5,931,820). Regarding claim 17, Schultz discloses the claimed invention substantially as claimed, as set forth above in claim 1. Schultz is silent regarding wherein the flow pattern comprises the lavage fluid being discharged at a pressure under 15 psi. However, Morse teaches wherein the flow pattern comprises the lavage fluid being discharged at a pressure under 15 psi (column 2, lines 17-19) for the purpose of irrigating a deep, contaminated wound). Therefore, it would have been prima facie obvious to one of ordinary skill in the art, before the effective filing of the claimed invention to modify the flow pattern of Schultz to incorporate wherein the flow pattern comprises the lavage fluid being discharged at a pressure under 15 psi as taught by Morse for the purpose of irrigating a deep, contaminated wound). Claims 18-20 are rejected under 35 U.S.C. 103 as being unpatentable over Schultz et al. (US 8,747,372 B1). Regarding claim 18, Schultz discloses the claimed invention substantially as claimed, as set forth above in claim 1. While Schultz discloses the flow pattern comprises of the lavage fluid being discharged in a spray wave (see figure 1) but is silent regarding the specifics of the spray wave of 6 square inches. There is no evidence of record that establishes that changing the spray wave would result in a difference in function of Schultz device. Further, a person having ordinary skill in the art, being faced with modifying the spray wave of Schultz would have a reasonable expectation of success in making such a modification and it appears the device would function as intended being given the claimed value and offering other values (10-1 inches, specification at paragraph 0075) and therefore, there appears to be no criticality placed on the range as claimed such that it produces an unexpected result. Therefore, it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to modify the spray wave of Schultz to have 6 square inches as an obvious matter of design choice within the skill of the art. Regarding claims 19 and 20, Schultz discloses the claimed invention substantially as claimed, as set forth above in claim 1. Schultz is silent regarding wherein the flow-adjusting member comprises a material selected from the group consisting of plastics, metals and alloys in one embodiment wherein the sealed body comprises a plastic that is compatible with gamma radiation. However, Schultz teaches in a different embodiment (figure 32) wherein the flow-adjusting member 64B comprises a material (column 18, lines 12-15) selected from the group consisting of plastics, metals, and alloys wherein the sealed body comprises a plastic (column 18, lines 12-15, PVC or polycarbonate are compatible with gamma radiation since this is same material that application has also disclosed in the specification on page 0085) that is compatible with gamma radiation for the purpose of using a well-known material that are biocompatible (column 18, lines 12-15). Therefore, it would have been prima facie obvious to one of ordinary skill in the art before the effective filing of the claimed invention to modify the material of the flow adjusting member of one embodiment of Schultz to incorporate wherein the flow-adjusting member comprises a material selected from the group consisting of plastics, metals and alloys wherein the sealed body comprises a plastic that is compatible with gamma radiation in one embodiment as taught by different embodiment of Schultz for the purpose of using a well-known material that are biocompatible (column 18, lines 12-15). Claim 21 is rejected under 35 U.S.C. 103 as being unpatentable over Schultz et al. (US 8,747,372 B1) in view of Gustafsson et al. (US 6,007,529). Regarding claim 21, Schultz discloses the claimed invention substantially as claimed, as set forth above in claim 1. Schultz is silent regarding wherein the sealed body and lavage fluid contained therein are terminally-sterilized via gamma radiation. However, Gustafsson teaches a design of a container for parental fluids (figure 1) wherein the sealed body and fluid contained therein are terminally-sterilized via gamma radiation (column 14, line 62-column 15, line 3) for the purpose of sterilizing the medical components with minimal risk for leakages and utility of a controlled atmosphere (column 15, lines 3-12). Therefore, it would have been prima facie obvious to one of ordinary skill in the art, before the effective filing of the claimed invention to modify the sealed body and lavage fluid of Schutz to incorporate wherein the sealed body and fluid (which is lavage fluid in Schultz modified in view of Gustafsson) contained therein are terminally-sterilized via gamma radiation as taught by Gustafsson for the purpose of sterilizing the medical components with minimal risk for leakages and utility of a controlled atmosphere (column 15, lines 3-12). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Paisley (US 2,168,270): discloses a design of a bottle that is connectable to a needle for establishing fluid connection through a seal. Any inquiry concerning this communication or earlier communications from the examiner should be directed to NILAY J SHAH whose telephone number is (571)272-9689. The examiner can normally be reached Monday-Thursday 8:00 AM-4:30 PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, CHELSEA STINSON can be reached at 571-270-1744. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /NILAY J SHAH/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Jan 06, 2025
Application Filed
Nov 06, 2026
Non-Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12779114
LEVERED IV FLOW REGULATION CLAMP ASSEMBLY
4y 5m to grant Granted Nov 03, 2026
Patent 12778848
PROCESS AND APPARATUS FOR PREPARING VISCOUS PHARMACEUTICAL FORMULATIONS
3y 9m to grant Granted Nov 03, 2026
Patent 12773525
SYSTEMS AND METHODS FOR DELIVERING PRESSURIZED FLUID TO A TARGET SITE ALONE OR IN CONJUNCTION WITH THERAPEUTIC AGENTS
4y 0m to grant Granted Oct 27, 2026
Patent 12766298
Bioelectronic Devices to Support Transplanted Cells in Vivo for Encapsulated Cell Therapies
4y 5m to grant Granted Oct 20, 2026
Patent 12766339
DISINFECTION DEVICE BASED ON LIGHT IN PROXIMITY TO SYRINGE
2y 11m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
76%
Grant Probability
99%
With Interview (+47.4%)
3y 2m (~1y 3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 617 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month